Table 4.
Development of Frailty in Human Immunodeficiency Virus HIV-Uninfected (HIV−) and HIV-Infected (HIV+) Nonfrail Men Followed After Measurement of Cytomegalovirus (CMV)-Induced IL-2-Producing CD4 T Cells
| IDa | HIV Status | Total CD4 IL-2 Response (% of CD4 T Cells) | Number of Follow-up Visitsb | Follow-up Visits with Fried Frailty Phenotype | |
|---|---|---|---|---|---|
| Number | Percent | ||||
| 1 | Negative | 0.05 | 12 | 1 | 8.3% |
| 2 | 0.20 | 12 | 1 | 8.3% | |
| 3 | 0.43 | 10 | 0 | 0% | |
| 4 | 0.96 | 9 | 0 | 0% | |
| 5 | 1.30 | 10 | 0 | 0% | |
| 6 | 2.27 | 14 | 4 | 28.6% | |
| 7 | 2.50 | 12 | 0 | 0% | |
| 8 | 3.62 | 13 | 4 | 30.8% | |
| 9 | 4.65 | 13 | 2 | 15.4% | |
| 10 | 5.15 | 12 | 4 | 33.3% | |
| 11 | Positive | 0.27 | 9 | 5 | 55.6% |
| 12 | 0.56 | 13 | 0 | 0% | |
| 13 | 0.64 | 13 | 3 | 23.1% | |
| 14 | 0.90 | 12 | 2 | 16.7% | |
| 15 | 0.93 | 10 | 0 | 0% | |
| 16 | 1.23 | 9 | 1 | 11.1% | |
| 17 | 1.30 | 12 | 1 | 8.3% | |
| 18 | 2.72 | 14 | 1 | 7.1% | |
| 19 | 3.95 | 13 | 0 | 0% | |
| 20 | 4.23 | 3 | 0 | 0% | |
aIdentifiers (IDs) are ranked in ascending order of the percentage of CD4 T cells that produced IL-2 in response to stimulation with CMV antigens.